Constitutively, activated state of EGFR, HER-2, and HER-3 in epithelial tumors consequence in aggressive tumor behaviors like initiation and extension of tumor growth, metastasis and chemoresistance, finally results into poor patient outcome [45,48,49]. The gene discussed is ERBB3; the disease is neoplasm.